InsidersTradesSigma
Total declarations
Companies
▲ Purchases (7 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
7
Disclosed sells
1
T+90 hit rate
29%
T+90 mean return
-11.6%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by DENNER ALEXANDER J, Director. Director active across 5 companies, notably Ironwood Pharmaceuticals INC. In total, 38 reports have been published. Split: 7 buys · 1 sell. Total volume traded: €8.5m. Activity tracked since 2 June 2021. The latest transaction was filed on 2 April 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations38 total
4,065 sharesClass A Common StockSEC:0001193125-26-274279:0
63,481 sharesClass A Common StockSEC:0001193125-26-274279:1
10,416 shares0Class A Common StockSEC:0000950170-25-051106:0
151,175 shares@ US$17.629130.0% of flowCommon Stock, par value $0.01 per shareSEC:0000899140-25-000405:0
4,249 shares0Class A Common StockSEC:0000950170-24-137870:0
3,282 shares0Class A Common StockSEC:0000950170-24-107770:0
24,311 shares0Class A Common StockSEC:0000950170-24-076216:0
2,572 shares0Class A Common StockSEC:0000950170-24-074833:0
1,662 shares0Class A Common StockSEC:0000950170-24-033454:0
1,347 shares0Class A Common StockSEC:0001209191-23-059112:0
1,798 shares0Class A Common StockSEC:0001209191-23-049996:0
22,350 shares0Class A Common StockSEC:0001209191-23-039133:0
62,000 shares@ US$13.13228.8% of flowCommon Stock, par value $0.01 per shareSEC:0000899140-23-000758:0
Ideal exit: 11 Mar 2024 (T+270)
1,359 shares0Class A Common StockSEC:0001209191-23-038339:0
7,000 shares@ US$13.04241.0% of flowCommon Stock, par value $0.01 per shareSEC:0000899140-23-000730:0
Ideal exit: 1 Mar 2024 (T+270)
50,000 shares@ US$13.08667.2% of flowCommon Stock, par value $0.01 per shareSEC:0000899140-23-000696:0
Ideal exit: 19 Feb 2024 (T+270)
50,000 shares@ US$13.07387.1% of flowCommon Stock, par value $0.01 per shareSEC:0000899140-23-000667:0
Ideal exit: 11 Feb 2024 (T+270)
50,000 shares@ US$13.07387.1% of flowCommon Stock, par value $0.01 per shareSEC:0000899140-23-000672:0
Ideal exit: 11 Feb 2024 (T+270)
290,000 shares@ US$12.335938.7% of flowCommon Stock, par value $0.01 per shareSEC:0000899140-23-000656:0
Ideal exit: 5 Feb 2024 (T+270)
1,438 shares0Class A Common StockSEC:0001209191-23-019596:0
1,244 shares0Class A Common StockSEC:0001209191-22-061864:0
1,374 shares0Class A Common StockSEC:0001209191-22-050483:0
1,370 shares0Common StockSEC:0001127602-22-017773:0
1,222 shares0Class A Common StockSEC:0001209191-22-038192:0
21,571 shares0Class A Common StockSEC:0001209191-22-033974:0
25 of 38 declarations
About DENNER ALEXANDER J
Alexander J. Denner serves as a Director at IRONWOOD PHARMACEUTICALS INC and BIOGEN INC. In these roles, he contributes to the governance of the companies and strategic decision-making. Denner leverages his experience to help guide the companies' policies and practices, ensuring compliance with regulations.
